Health

Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access

-- FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance --…

4 months ago

The International Myeloma Foundation Invites the Myeloma Community to Demonstrate the Spirit of #MoreThanMyeloma for 2026 Myeloma Action Month

STUDIO CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Every March, the International Myeloma Foundation (IMF) leads Myeloma Action Month…

4 months ago

Curaechoice and Fast Pace Health Partner to Expand Affordable Healthcare Access Across Multiple States

Curaechoice members now have enhanced access to covered services at over 300 Fast Pace Health clinics at $0 cost February…

4 months ago

The Integrated Healthcare Association Recognizes California Provider Organizations for Medicare Advantage Performance

OAKLAND, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Integrated Healthcare Association (IHA) today announced top-performing provider organizations and those…

4 months ago

IBA TRANSPARENCY NOTIFICATION

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February…

4 months ago

Amwell to Participate in Upcoming Investor Conference

February 24, 2026 17:00 ET  | Source: Amwell BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading…

4 months ago

Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update

February 24, 2026 16:30 ET  | Source: Cardiff Oncology, Inc. Reported positive update from Phase 2 CRDF-004 trial in first-line…

4 months ago

Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

New directors bring decades of financial leadership and board experience to enhance strategic oversight of Return-to-Growth action plan and long-term…

4 months ago

Supernus Pharmaceuticals to Participate in March Investor Conferences

February 23, 2026 18:15 ET  | Source: Supernus Pharmaceuticals, Inc. ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals,…

4 months ago

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

ROCKVILLE, MD, Feb. 23, 2026 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative…

4 months ago